Choroidal Neovascularization Market Report by Product Type (Intravenous, Intravitreal), Diagnosis (Fluorescein Angiography (FA), Indocyanine Green (ICG) Angiography, Spectral Domain Optical Coherence Tomography (OCT), and Others), Treatment Type (Angiogenesis Inhibitors Injection, Photodynamic Therapy, Laser photocoagulation, Low-dose Radiation Therapy, Surgery), Application (Extreme Myopia, Malignant Myopic Degeneration, Age-Related Developments), and Region 2026-2034

Choroidal Neovascularization Market Report by Product Type (Intravenous, Intravitreal), Diagnosis (Fluorescein Angiography (FA), Indocyanine Green (ICG) Angiography, Spectral Domain Optical Coherence Tomography (OCT), and Others), Treatment Type (Angiogenesis Inhibitors Injection, Photodynamic Therapy, Laser photocoagulation, Low-dose Radiation Therapy, Surgery), Application (Extreme Myopia, Malignant Myopic Degeneration, Age-Related Developments), and Region 2026-2034

Report Format: PDF+Excel | Report ID: SR112026A2561

Market Overview:

The global choroidal neovascularization market size reached USD 7.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 12.5 Billion by 2034, exhibiting a growth rate (CAGR) of 5.88% during 2026-2034.

Report Attribute 
Key Statistics
Base Year
2025
Forecast Years
2026-2034
Historical Years
2020-2025
Market Size in 2025
USD 7.4 Billion
Market Forecast in 2034
USD 12.5 Billion
Market Growth Rate 2026-2034 5.88%

Choroidal neovascularization (CNV) refers to the creation of new blood vessels in the choroid layer of the eyes affecting the Bruch's membrane and retinal pigment epithelium (RPE). Its symptoms include lipid exudation, subretinal blood and fluid, and distortion, waviness and black spots in the central vision. At present, a combination of procedures, such as fluorescein angiography (FA), indocyanine green (ICG) angiography and optical coherence tomography (OCT) scanning, are utilized for diagnosing CNV. As per the results, doctors then prescribe anti-vascular endothelial growth factor (VEGF) drugs, thermal laser treatment and photodynamic therapy (PDT), to prevent the growth of the blood vessels.

Choroidal Neovascularization Market Size

To get more information on this market Request Sample

The market is experiencing growth on account of the rising prevalence of age-related macular degeneration (ARMD), ocular histoplasmosis, pathologic myopia, angioid streaks, choroidal tears and inflammatory diseases of the choroid and retina. Moreover, the increasing geriatric population, which is more vulnerable to serious health conditions, is acting as another key factor bolstering the market growth. Furthermore, the growing adoption of combination drugs, along with the introduction of long-lasting anti-VEGF drugs, is propelling the demand for CNV treatments worldwide. Other factors, such as improving healthcare infrastructure and the increasing investments in research and development (R&D) activities, are also contributing to the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global choroidal neovascularization market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on product type, type of diagnosis, treatment type and application.

Breakup by Product Type:

  • Intravenous
  • Intravitreal
     

Breakup by Type of Diagnosis:

  • Fluorescein Angiography (FA)
  • Indocyanine Green (ICG) Angiography
  • Spectral Domain Optical Coherence Tomography (OCT)
  • Others
     

Breakup by Treatment Type:

  • Angiogenesis Inhibitors Injection
  • Photodynamic Therapy
  • Laser photocoagulation
  • Low-dose Radiation Therapy
  • Surgery
     

Breakup by Application:

Choroidal Neovascularization Market By Application

Access the comprehensive market breakdown Request Sample

  • Extreme Myopia
  • Malignant Myopic Degeneration
  • Age-Related Developments
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Bausch Health Companies Inc., Bayer AG, Gilead Sciences, Inc., F. Hoffmann-La Roche AG, MaaT Pharma, Novartis AG, Pfizer Inc., Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited), Regeneron Pharmaceuticals Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.).

Report Coverage:

Report Features Details
Base Year of the Analysis 2025
Historical Period 2020-2025
Forecast Period 2026-2034
Units Billion USD
Segment Coverage Product Type, Type of Diagnosis, Treatment Type, Application, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Bausch Health Companies Inc., Bayer AG, Gilead Sciences, Inc., F. Hoffmann-La Roche AG, MaaT Pharma, Novartis AG, Pfizer Inc., Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited), Regeneron Pharmaceuticals Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.)
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the global choroidal neovascularization market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global choroidal neovascularization market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the type of diagnosis?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global choroidal neovascularization market and who are the key players?
  • What is the degree of competition in the industry?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Choroidal Neovascularization Market Report by Product Type (Intravenous, Intravitreal), Diagnosis (Fluorescein Angiography (FA), Indocyanine Green (ICG) Angiography, Spectral Domain Optical Coherence Tomography (OCT), and Others), Treatment Type (Angiogenesis Inhibitors Injection, Photodynamic Therapy, Laser photocoagulation, Low-dose Radiation Therapy, Surgery), Application (Extreme Myopia, Malignant Myopic Degeneration, Age-Related Developments), and Region 2026-2034
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-201-971-6302

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials